Evidence-Based, Patient-Centered Treatment Selection and Sequencing in Chronic Graft-Versus-Host Disease

Join our comprehensive program tailored to provide personalized education based on your existing knowledge on the latest evidence in the treatment of chronic graft-versus-host disease (cGVHD). Through this program, you'll gain insights into evaluating clinical data to select and sequence evidence-based, patient-centered treatment plans for cGVHD that align with clinical guidelines and patients' goals and preferences.

• Evaluate the latest guidelines and clinical safety and efficacy data for current and emerging treatment strategies for cGVHD
• Employ evidence-based strategies to personalize treatment selection and sequencing for cGVHD, including cases of steroid-refractory disease
• Assess patient-centered perspectives concerning the impact of cGVHD diagnosis and disease burden to guide treatment decisions

• 0.5 CME/CE for Physicians (ACCME)
• 0.5 CME/CE for Physician Assistants (AAPA)
• 0.5 CH/CE for Nurse Practitioners (AANP)
• 0.5 CPE for Pharmacists (ACPE + NABP)
• 0.5 CNE for Nurses (ANCC)

This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by an educational grant from Sanofi US.